Abstract
The gamma amino butyric acid (GABA) transporters GAT-1 and GAT-3 were localized by immunohistochemistry in hippocampi removed for the control of medically intractable temporal lobe epilepsy (TLE). The study aimed to determine the relationship of GABA transporter expression to known patterns of hippocampal hyperexcitability and extracellular GABA levels. GAT-1 was localized in axon terminals and small neuronal cell bodies, and in non-sclerotic hippocampi was strongly expressed throughout all regions of the hippocampal formation. In the epileptogenic hippocampus exhibiting Ammon’s horn sclerosis, immunoreactivity was reduced in the sclerotic regions CA3 and CA1, and around the cell bodies of dentate granule cells, but was increased along granule cell dendrites. GAT-3 was weakly expressed, if at all, in non-sclerotic hippocampi, but more prominently expressed in sclerotic hippocampi. GAT-3 expression was confined to cells resembling protoplasmic astrocytes, which were located in regions of relative neuronal sparing such as the dentate gyrus and hilus of the sclerotic hippocampus. The reduction in GAT-1 around granule cells in the sclerotic hippocampus could explain the prolonged GABA responses in this region. The loss of GAT-1 (a marker of GABAergic terminals) would also suggest a reduced GABAergic input to the granule cells, thus facilitating hyperexcitability. The increased GAT-3 expression in astrocytes in regions of relative neuronal sparing in the sclerotic hippocampus may be related to the overall low levels of extracellular GABA observed in the sclerotic hippocampus and their increased excitability.
Similar content being viewed by others
References
Arellano JI, Muñoz A, Ballesteros-Yáñez I, Sola RG, DeFilipe J (2003) Histopathology and reorganization of chandelier cells in the human epileptic sclerotic hippocampus. Brain 127:45–64
Babb TL, Pretorius JK, Crandall PH (1989) Glutamate decarboxylase-immunoreactive neurons are preserved in human epileptic hippocampus. J Neurosci 9:2562–2574
Barnard C, Costar R, Hirsch JC, Escapes M, Ben-Ari Y (2000) What is GABAergic inhibition? How is it modified in epilepsy? Epilepsia 41:S90–S95
Borden LA (1996) GABA transporter heterogeniety: pharmacology and cellular localization. Neurochem Int 29:335–356
Brines ML, Sundaresan S, Spencer DD, de Lanerolle NC (1997) Quantitative autoradiographic analysis of ionotropic glutamate receptor subtypes in human temporal lobe epilepsy: upregulation in reorganized epileptogenic hippocampus. Eur J Neurosci 9:2035–2044
Cammack JN, Rakhilin SV, Schwartz EA (1994) A GABA transporter operates asymmetrically with variable stoichiometry. Neuron 13:949–960
Cammack JN, Schwartz EA (1993) Ions required for the electrogenic transport of GABA by horizontal cells of the catfish retina. J Physiol (Lond) 472:81–102
Conti F, Minelli A, Melone M (2004) GABA transporters in the mammalian cerebral cortex: localization, development and pathological implications. Brain Res Rev 45:196–212
Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65:1–105
Danbolt NC, Lehre KP, Dehnes Y, Chaudhry FA, Levy LM (1998) Localization of transporters using transporter-specific antibodies. Methods Enzymol 296:388–407
Danbolt NC, Pines G, Kanner BI (1990) Purification and reconstitution of the sodium- and potassium-coupled glutamate transport glycoprotein from rat brain. Biochemistry 29:6734–6740
de Lanerolle NC, Eid T, von Campe G, Kovacs I, Spencer DD, Brines M (1998) Glutamate receptor subunits GluR1 and GluR2/3 distribution shows reorganization in the human epileptogenic hippocampus. Eur J Neurosci 10:1687–1703
de Lanerolle NC, Kim JH, Robbins RJ, Spencer DD (1989) Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy. Brain Res. 495:387–395
de Lanerolle NC, Kim JH, Williamson A, Spencer SS, Zaveri HP, Eid T, Spencer DD (2003) A retrospective analysis of hippocampal pathology in human temporal lobe epilepsy: evidence for distinctive patient subcategories. Epilepsia 44:677–687
de Lanerolle NC, Williamson A, Meredith C, Kim JH, Tabuteau H, Spencer DD, Brines ML (1997) Dynorphin and the kappa 1 ligand [3H]-U69,539 binding in the human epileptogenic hippocampus. Epilepsy Res 28:189–205
DeFelipe J, Gonzalez-Albo MDC (1998) Chandelier cell axons are immunoreactive for GAT1 in the human neocortex. NeuroReport 9:467–470
During MJ, Ryder KM, Spencer DD (1995) Hippocampal GABA transporter function in temporal-lobe epilepsy. Nature 376:174–177
During MJ, Spencer DD (1993) Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain. Lancet 341:1607–1610
Durkin MM, Smith KE, A BL, Weinshank RL, Branchek TA, Giustaffson EL (1995) Localization of messenger RNAs encoding three GABA transporters in rat brain: an in situ hybridization study. Mol Brain Res 33:7–21
Fried I, Kim JH, Spencer DD (1992) Hippocampal pathology in patients with intractable seizures and temporal lobe masses. J Neurosurg 76:735–740
Houser CR, Miyashiro JE, Swartz BE, Walsh GO, Rich JR, Delgado-Escueta AV (1990) Altered patterns of dynorphin immunoreactivity suggest mossy fiber reorganization in human hippocampal epilepsy. J Neurosci 10:267–282
Ikegaki N, Saitoh N, Hashima M, Tanaka C (1994) Production of specific antibodies against GABA transporter subtypes (GAT1, GAT2, GAT3) and their application to immunocytochemistry. Mol Brain Res 26:47–54
Isokawa M, Avanzini G, Finch DM, Babb TL, Levesque MF (1991) Physiological properties of human dentate granule cells in slices prepared from epileptic patients. Epilepsy Res 9:242–250
Johnson EW, de Lanerolle NC, Kim JH, Sundaresan S, Spencer DD, Mattson RH, Zoghbi SS, Baldwin RM, Hoffer PB, Seibyl JP, Innis RB (1992) Central and peripheral benzodiazepine receptors: opposite changes in human epileptic tissue. Neurology 42:811–815
Jursky F, Tamura S, Tamura A, Mandiyan S, Nelson H, Nelson N (1994) Structure, function and brain localization of neurotransmitter transporters. J Exp Biol 196:283–295
Kaila R, Rydqvist B, Pasternack M, Voipio J (1992) Inward current caused by sodium dependent uptake of GABA in the crayfish stretch receptor neuron. J Physiol (Lond) 453:627–645
Kim JH, Guimaraes PO, Shen M-Y, Masukawa LM, Spencer DD (1990) Hippocampal neuronal density in temporal lobe epilepsy with and without gliomas. Acta Neuropathol 80:41–45
Knowles WD, Awad IA, Nayel MH (1992) Differences in in vitro electrophysiology of hippocampal neurons from epileptic patients with mesiotemporal sclerosis versus structural lesions. Epilepsia 33:601–609
Lloyd KG, Bossi L, Morselli PL (1985) Biochemical evidence for dysfunction of GABA neurons in human epilepsy. In: Bartholini G, Bossi L, Lloyd KG (eds) Epilepsy and GABA receptor agonists: basic and therapeutic research, Raven Press, New York, pp 43–51
Masukawa L, Higashima M, Kim J, Spencer DD (1989) Epileptiform discharges evoked in hippocampal brain slices from epileptic patients. Brain Res 493:168–174
Mathern GW, Babb TL, Armstrong DL (1997) Hippocampal sclerosis. In: Engel J, Pedley TA (eds) Epilepsy: a comprehensive textbook, Lippincott-Raven, Philadelphia, pp 133–155
Mathern GW, Mendoza D, Lozada A, Pretorius JK, Dehnes Y, Danbolt NC, Nelson N, Leite JP, Chimelli L, Born DE, Sakamoto AC, Assirati JA, Fried I, Peacock WJ, Ojemann GA, Adelson PD (1999) Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy. Neurology 52:453–472
Patrylo PR, Spencer DD, Williamson A (2001) GABA uptake and heterotransport are impaired in the dentate gyrus of epileptic rats and humans with temporal lobe sclerosis. J Neurophysiol 85:1533–1542
Radian R, Ottersen OP, Storm-mathisen J, Castel M, Kanner BI (1990) Immunocytochemical localization of the GABA transporter in rat brain. J Neurosci 10:1319–1330
Sayin U, Osting S, Hagen J, Rutecki P, Sutula TP (2003) Spontaneous seizures and loss of axo-axonic and axo-somatic inhibition induced by repeated brief seizures in kindled rats. J Neurosci 23:2759–2768
Spencer DD (1994) Classifying the epilepsies by substrate. Clin Neurosci 2:104–109
Spencer DD, Inserni J (1991) Temporal lobectomy. In: Lüders HO (ed) Epilepsy surgery, Raven Press Ltd., New York, pp 533–545
Spencer DD, Spencer SS, Mattson RH, Williamson PD, Novelly R (1984) Access to posterior medial temporal lobe structures in the surgical treatment of temporal lobe epilepsy. Neurosurgery 15:667–671
Williamson A (1994) Electrophysiology of epileptic human neocortical and hippocampal neurons maintained in vitro. Clin Neurosci 2:47–52
Williamson A, Spencer SS, Spencer DD (1995) Depth electrode studies and intracellular dentate granule cell recordings in temporal lobe epilepsy. Ann Neurol 38:778–787
Acknowledgments
We thank Ms. Ilona Kovacs for her excellent technical assistance with the immunohistochemistry. We are indebted to Professor N.C. Danbolt for providing us with GAT1 antibodies. Some of the data reported here was part of the Senior Thesis of Carlos Paz at Yale College.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, TS., Bjørnsen, L.P., Paz, C. et al. GAT1 and GAT3 expression are differently localized in the human epileptogenic hippocampus. Acta Neuropathol 111, 351–363 (2006). https://doi.org/10.1007/s00401-005-0017-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-005-0017-9